CDNA
CareDx, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website caredx.com
- Employees(FY) 727
- ISIN US14167L1035
Performance
+40.14%
1W
+97.45%
1M
+90.65%
3M
+69.77%
6M
+29.17%
YTD
+99.49%
1Y
Profile
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Technical Analysis of CDNA 2024-05-10
Overview:
In analyzing the technical indicators for CDNA over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed deci...
Recent News & Updates
- 2024-05-16 16:05
- 2024-05-16 04:05
- 2024-05-14 07:17
- 2024-05-13 10:12
- 2024-05-11 08:13
- 2024-05-10 14:26
CareDx Shares Rise After Q1 Results Beat Estimates(MT Newswires)
- 2024-05-10 14:21
- 2024-05-10 11:46
CareDx, Inc (NASDAQ:CDNA) Q1 2024 Earnings Call Transcript(Insider Monkey)
- 2024-05-09 19:00
- 2024-05-09 17:32
CareDx: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-09 16:05
CareDx Reports First Quarter 2024 Results(Business Wire)
- 2024-05-09 04:05
CareDx Reports First Quarter 2024 Results(Businesswire)
- 2024-05-07 09:15
- 2024-05-06 21:15
- 2024-05-03 16:10
- 2024-05-03 04:10
- 2024-04-29 16:05
CareDx to Report First Quarter 2024 Financial Results(Business Wire)
- 2024-04-29 04:05
CareDx to Report First Quarter 2024 Financial Results(Businesswire)
- 2024-04-19 16:05
- 2024-04-19 04:05
- 2024-04-18 03:47
- 2024-04-17 15:47
- 2024-04-16 16:02
- 2024-04-16 04:02
- 2024-04-09 07:00
- 2024-04-08 19:00
- 2024-04-01 08:40
- 2024-03-31 20:40
- 2024-03-11 16:10
CareDx Appoints Bryan Riggsbee to Its Board of Directors(Business Wire)
- 2024-03-11 04:10
CareDx Appoints Bryan Riggsbee to Its Board of Directors(Businesswire)
Page 1 of 6
previousnext